Page 3 - Louism Weiner News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Louism weiner. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Louism Weiner Today - Breaking & Trending Today

Jounce Therapeutics (NASDAQ:JNCE) Now Covered by Analysts at StockNews.com

Stock analysts at StockNews.com assumed coverage on shares of Jounce Therapeutics (NASDAQ:JNCE – Get Rating) in a research report issued to clients and investors on Monday. The brokerage set a “hold” rating on the stock. JNCE has been the subject of several other reports. Piper Sandler cut Jounce Therapeutics from an “overweight” rating to a […] ....

United States , United Kingdom , Raymond James , Thomasf Gajewski , Kevinc Tang , Robert Schreiber , Jamesp Allison , Padmanee Sharma , Piper Sandler , Louism Weiner , Silverarc Capital Management , American International Group Inc , Sumitomo Mitsui Financial Group , Jounce Therapeutics Inc , Cubist Systematic Strategies , Securities Exchange Commission , Principal Financial Group Inc , Jounce Therapeutics , Get Rating , Mitsui Financial Group , Exchange Commission , Director Richard , Capital Management , International Group , Financial Group , Systematic Strategies ,

Short Interest in Jounce Therapeutics, Inc. (NASDAQ:JNCE) Declines By 11.4%

Jounce Therapeutics, Inc. (NASDAQ:JNCE – Get Rating) was the recipient of a large drop in short interest in April. As of April 15th, there was short interest totalling 2,020,000 shares, a drop of 11.4% from the March 31st total of 2,280,000 shares. Based on an average trading volume of 2,640,000 shares, the days-to-cover ratio is […] ....

United Kingdom , Louism Weiner , Padmanee Sharma , Piper Sandler , Raymond James , Jamesp Allison , Robert Schreiber , Kevinc Tang , Thomasf Gajewski , Health Sciences , Virtu Financial , Susquehanna International Group , Capital Management , Moloney Securities Asset Management , Jounce Therapeutics Inc , Sumitomo Mitsui Financial Group , Securities Exchange Commission , Jounce Therapeutics , Get Rating , Exchange Commission , Director Richard , International Group , Securities Asset Management , Mitsui Financial Group , Jounce Therapeutics Daily , Nasdaq Jnce ,

Jounce Therapeutics (NASDAQ:JNCE) Now Covered by StockNews.com

StockNews.com started coverage on shares of Jounce Therapeutics (NASDAQ:JNCE – Get Rating) in a research report sent to investors on Sunday morning. The firm issued a hold rating on the stock. A number of other analysts have also weighed in on the stock. Sumitomo Mitsui Financial Group restated a neutral rating on shares of Jounce […] ....

United Kingdom , Raymond James , Robert Schreiber , Louism Weiner , Jamesp Allison , Kevinc Tang , Padmanee Sharma , Piper Sandler , Thomasf Gajewski , Jounce Therapeutics Company Profile , Investment Advisers , Virtu Financial , Capital Management , Securities Exchange Commission , Squarepoint Ops , Voya Investment Management , Sumitomo Mitsui Financial Group , Jounce Therapeutics Inc , Jounce Therapeutics , Get Rating , Mitsui Financial Group , Exchange Commission , Director Richard , Investment Management , Jounce Therapeutics Daily , Nasdaq Jnce ,

Brokerages Set Jounce Therapeutics, Inc. (NASDAQ:JNCE) Target Price at $8.00

Jounce Therapeutics, Inc. (NASDAQ:JNCE – Get Rating) has received a consensus rating of “Hold” from the six ratings firms that are covering the company, Marketbeat.com reports. Four investment analysts have rated the stock with a hold rating and one has issued a buy rating on the company. The average 1-year price target among brokers that […] ....

United Kingdom , Jamesp Allison , Raymond James , Padmanee Sharma , Thomasf Gajewski , Kevinc Tang , Louism Weiner , Robert Schreiber , Piper Sandler , Sumitomo Mitsui Financial Group , Investment Advisers , Capital Management , Health Sciences , Wealth Group , Jounce Therapeutics Inc , Jounce Therapeutics Company Profile , Balyasny Asset Management , Jounce Therapeutics , Get Rating , Mitsui Financial Group , Director Richard , Asset Management , Jounce Therapeutics Daily , Nasdaq Jnce ,

Susquehanna International Group LLP Purchases 26,125 Shares of Jounce Therapeutics, Inc. (NASDAQ:JNCE)

Susquehanna International Group LLP boosted its position in Jounce Therapeutics, Inc. (NASDAQ:JNCE – Get Rating) by 824.9% in the 4th quarter, HoldingsChannel.com reports. The firm owned 29,292 shares of the company’s stock after buying an additional 26,125 shares during the period. Susquehanna International Group LLP’s holdings in Jounce Therapeutics were worth $33,000 as of its […] ....

United Kingdom General , United Kingdom , United States , Jamesp Allison , Louism Weiner , Kevinc Tang , Raymond James , Piper Sandler , Thomasf Gajewski , Padmanee Sharma , Robert Schreiber , Citadel Advisors , Health Sciences , Jounce Therapeutics Company Profile , Exchange Commission , Jounce Therapeutics Inc , Securities Exchange Commission , Sumitomo Mitsui Financial Group , Susquehanna International Group , Blackrock Inc , America Corp , Jounce Therapeutics , Get Rating , International Group , Mitsui Financial Group , Director Richard ,